Synchronous primary cancers in a woman with scleroderma: a case report

Background: Scleroderma is a chronic, multisystem, autoimmune disease. Previous studies have shown an increased risk of malignancy in scleroderma; the most common cancers were lung cancer and breast cancer. Case: The patient. a 43-year-old nulliparous premenopausal Greek woman with scleroderma, presented with a history of abdominal pain and atypical vaginal bleeding. She underwent total hysterectomy with bilateral salpingo-oophorectomy, total omentectomy, appendectomy and pelvic lymph node dissection. The histopathology revealed synchronous primary cancers of the endometrium and left ovary. She underwent postoperative chemotherapy and remains well without evidence of disease 25 months after surgery. Conclusion: Synchronous primary cancers of the endometrium and ovary are relatively uncommon in the general population. Only a few cases of cancer of the female genital tract in women with scleroderma have been reported in the English literature.

Synchronous primary cancers; Scleroderma; Endometrial cancer; Ovarian cancer

[1] Hill C.L., Nguyen A.M., Roder D., Roberts-Thomson P.: “Risk of cancer in patients with scleroderma: a population based cohort study”. Ann. Rheum. Dis., 2003, 62, 728.

[2] Pearson Je., Silman A.J.: “Risk of cancer in patients with scleroderma”. Ann. Rheum. Dis., 2003, 62, 697.

[3] Chatterjee S., Dombi G.W., Severson R.K., Mayes M.: “Risk of Malignancy in Scleroderma. A population based cohort study”. Arthritis Rheum., 2005, 52, 2415.

[4] Eifel P., Hendrickson M., Ross J., Ballon S., Martinez Z., Kempson R.: “Simultaneus presentation of carcinoma involving the ovary and the uterine corpus”. Cancer, 1982, 50, 163.

[5] Herrinton L.,Voigt L.,Weiss N., Beresford S.,Wingo P.: “Risk factors for synchronous primary endometrial and ovarian cancers”. Ann. Epidemiol., 2001, 11, 529.

[6] Soliman P.T., Slomovitz B.M., Broaddus R.R., Sun C.C., OH J.C., Eifel P.J., Gershenson D.M., Lu K.H.: “Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases”. Gynecol. Oncol., 2004, 94, 456.

[7] Zaino R., Whitney C., Brady M., DeGeest K., Burger R., Buller R.: “Simultaneously detected endometrial and ovarian carcinomas - a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group Study”. Gynecol. Oncol., 2001, 83, 355.

[8] Pearl M.L., Johnston C.M., Frank T.S., Roberts J.A.: “Synchronous dual primary ovarian and endometrial carcinomas”. Int. J. Gynecol. Obstet., 1993, 43, 305.

[9] Ayhan A., Guvenal T., Coskun F., Basaran M., Salman M.C.: “Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers metastatic to the ovaries”. Eur. J. Gynaecol. Oncol., 2003, 24, 171.

[10] Sheu B.C., Lin H.H., Chen C.K., Chao K.H., Shun C.T., Huang S.C.: “Synchronous primary carcinomas of the endometrium and ovary”. Int. J. Gynecol. Obstet., 1995, 51, 141.